FIELD: medicine. SUBSTANCE: method involves acting directly upon the infection focus in the respiratory tract with aerosol containing proteinase inhibitors. Aerosol form of the active agent is usable for treating human beings and animals in cases of broad gamma of respiratory diseases invoked by influenza, paragrippe, measles, parotiditis vires, respiratory syncytial virus, mitra virus, adenovirus, rhinovirus and others. EFFECT: enhanced effectiveness in treating viral infections. 2 cl, 4 dwg
| Title | Year | Author | Number |
|---|---|---|---|
| APROTININ AEROSOL FOR TREATING VIRAL RESPIRATORY INFECTIONS | 2010 |
|
RU2425691C1 |
| PHARMACEUTICAL AEROSOL COMPOSITION OF POLYVALENT ACTION | 2021 |
|
RU2781097C1 |
| EMULSION PREPARATION FOR PROPHYLAXIS OF RESPIRATORY VIRAL INFECTIONS | 2001 |
|
RU2189231C1 |
| COMBINED AEROSOL COMPOSITION BASED ON PROTEASE INHIBITORS AND PREPARATION THEREOF | 2015 |
|
RU2711080C2 |
| DRUG FOR TREATMENT OF PATIENTS WITH VIRAL DISEASE | 1994 |
|
RU2118163C1 |
| PHARMACEUTICAL AEROSOL COMPOSITION OF PROTEASE INHIBITORS WITH OZONE-PRESERVING PROPELLANT AND ITS PREPARATION | 2011 |
|
RU2657523C2 |
| AGENT WITH ANTIVIRAL ACTIVITY AGAINST INFLUENZA A AND SARS-CoV-2 VIRUSES | 2022 |
|
RU2796748C1 |
| APPLICATION OF ACETYLSALICYLIC ACID SALT FOR TREATMENT OF VIRAL INFECTIONS | 2009 |
|
RU2524304C2 |
| MEANS FOR PREVENTION OF INTERSTITIAL PNEUMONIA | 2020 |
|
RU2747550C1 |
| ANTI-SARS-COV-2 VIRAL AGENT ANTIPROVIR | 2020 |
|
RU2738885C1 |
